Summary Rickets is a metabolic bone disease caused by a defect in mineralization of osteoid matrix caused by inadequate calcium and phosphate that occurs prior to closure of the physes. Patients present with characteristic features such as bowing of long bones, ligamentous laxity, brittle bones and enlargement of costal cartilage. Diagnosis is made based on a thorough evaluation of serum labs, clinical features, and radiographic findings. Treatment involves medical management to resolve the underlying etiology of rickets. Etiology Pathophysiology Vitamin D and PTH play an important role in calcium homeostasis disruption of calcium/phosphate homeostasis poor calcification of cartilage matrix of growing long bones occurs at zone of provisional calcification leads to increased physeal width and cortical thinning/bowing Mechanism rickets is known as osteomalacia if it occurs after physeal closure can be congenital or acquired treatment is usually non-operative with supplementation Associated conditions orthopaedic manifestations include brittle bones with physeal cupping/widening bowing of long bones ligamentous laxity flattening of skull enlargement of costal cartilage (rachitic rosary) kyphosis (cat back) Classification Vitamin D-resistant (familial hypophosphatemic) most common form of heritable rickets presents at 1-2 years of age caused by inability of renal tubules to absorb phosphate GFR is normal vitamin D3 response is impaired genetics X-linked dominant login to view 3 more bullets autosomal dominant login to view 2 more bullets autosomal recessive login to view 2 more bullets Vitamin D-deficient (nutritional) results from decreased dietary intake of Vitamin D rare now that Vitamin D is added to milk presents at 6 months - 3 years of age risk factors premature infants black children > 6 months who are still breastfed patients with malabsorption syndromes (celiac sprue) or chronic parenteral nutrition Asian immigrants patients with unusual dietary choices (vegetarian diet) pathophysiology low Vitamin D levels lead to decreased intestinal absorption of calcium low calcium levels leads to a compensatory increase in PTH and bone resorption bone resorption leads to increased alkaline phosphatase levels Vitamin D-dependent (type I & type II) rare disorder leads to clinical features similar to Vitamin D-deficient rickets but more severe clinical characteristics type I login to view 1 more bullet type II login to view 1 more bullet pathophysiology type I login to view 4 more bullets type II login to view 2 more bullets Presentation Symptoms listlessness irritability generalized weakness Physical exam tibial bowing due to widened proximal tibial physes rachitic rosary enlargement of costochondral junction bowing of knees retarded bone growth muscle hypotonia waddling gait dental abnormalities delayed dental eruption defective enamel pathologic fractures Imaging Radiographs recommended views AP and lateral of affected bone findings physeal widening metaphyseal cupping decreased bone density Looser's zones login to view 1 more bullet rachitic rosary login to view 1 more bullet lower extremity bowing login to view 1 more bullet codfish vertebrae cat back login to view 1 more bullet Studies Serum labs Histology disordered and elongated zone of proliferation poorly defined zone of provisional calcification widened osteoid seams "swiss cheese" trabeculae abnormally arranged collagen fibers run perpendicular to haversian canals Tested Differential Renal osteodystrophy Hypophosphatasia Treatment Nonoperative calcitriol indications login to view 2 more bullets phosphate replacement indications login to view 1 more bullet Vitamin D indications login to view 2 more bullets Calcium indications login to view 1 more bullet Burosumab human monoclonal antibody to FGF-23 approved for the treatment of X-linked hypophosphatemia among children 1 year and older Operative corrective surgery (multilevel osteotomy) indications login to view 1 more bullet Techniques Calcitriol technique 20-30 μg/kg/day split into 2-3 doses in children 0.5-0.75 μg/day split into 2 doses in adults Phosphate replacement technique 20-40 mg/kg/day split into 3-5 doses in children 750-1000 mg/day split into 3-4 doses in adults Must be given in combination with active vitamin D (i.e. calcitriol) in XLH patients, as this prevents the development of secondary hyperparathyroidism as seen in patients treated with phosphate salts alone Vitamin D technique 5000 IU/day for 6-10 weeks Corrective surgery (multilevel osteotomy) technique variety of fixation devices including K-wires, plates, intramedullary nails, and/or external fixation